Skip to main content

Posters

Recent Posters

Posters  —  10 November Nov 2022

The immune expression landscape of solid tumors with tertiary lymphoid structures

Read More about The immune expression landscape of solid tumors with tertiary lymphoid structures
Posters  —  6 November Nov 2022

Opportunities and Challenges for Innovative Drugs in China: Strategies for successful reimbursement

Read More about Opportunities and Challenges for Innovative Drugs in China: Strategies for successful reimbursement
Posters  —  6 November Nov 2022

How Health Technology Assessment Agencies View Clinical Evidence for Tumor Agnostic Therapies

Read More about How Health Technology Assessment Agencies View Clinical Evidence for Tumor Agnostic Therapies
Posters  —  6 November Nov 2022

The Challenges of Outcomes-Based Reimbursement for Advanced Therapy Medicinal Products in Europe

Read More about The Challenges of Outcomes-Based Reimbursement for Advanced Therapy Medicinal Products in Europe
Posters  —  6 November Nov 2022

A Novel Approach for Minimizing Immortal Time Bias in Observational Studies

Read More about A Novel Approach for Minimizing Immortal Time Bias in Observational Studies
Posters  —  6 November Nov 2022

An Exploration of Patient Involvement in NICE and SMC Appraisals of Breast and Ovarian Cancer Therapies

Read More about An Exploration of Patient Involvement in NICE and SMC Appraisals of Breast and Ovarian Cancer Therapies
Posters  —  6 November Nov 2022

National Institute of Health and Care Excellence (NICE) assessment of Highly Specialist Technologies (HST): what factors determine restricted reimbursement?

Read More about National Institute of Health and Care Excellence (NICE) assessment of Highly Specialist Technologies (HST): what factors determine restricted reimbursement?
Posters  —  6 November Nov 2022

Propensity Score Matching: Role of Clinical Expertise in a Data-Driven Approach to Model Selection

Read More about Propensity Score Matching: Role of Clinical Expertise in a Data-Driven Approach to Model Selection
Posters  —  4 November Nov 2022

Pan solid tumor identification of NRG1 fusions utilizing RNA sequencing identifies diverse fusion partners and highlights a lack of co-occurring oncogenic driver alterations

Read More about Pan solid tumor identification of NRG1 fusions utilizing RNA sequencing identifies diverse fusion partners and highlights a lack of co-occurring oncogenic driver alterations
Posters  —  4 November Nov 2022

Assessing variability across HRD assays: Findings from the friends’ HRD harmonization project

Read More about Assessing variability across HRD assays: Findings from the friends’ HRD harmonization project
Posters  —  4 November Nov 2022

Combined low-pass whole genome and targeted sequencing identifies causative mutations and associated genomic scarring indicative of homologous recombination deficiency

Read More about Combined low-pass whole genome and targeted sequencing identifies causative mutations and associated genomic scarring indicative of homologous recombination deficiency
Posters  —  4 November Nov 2022

Validation of genomic profiling by PGDx Plasma Focus to facilitate precision oncology through cell-free DNA testing of solid tumors

Read More about Validation of genomic profiling by PGDx Plasma Focus to facilitate precision oncology through cell-free DNA testing of solid tumors